Compare Elanco Animal Health Incorporated Common Stock (ELAN) vs Kimberly Clark Corp (KMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Elanco Animal Health Incorporated Common Stock vs Kimberly Clark Corp — how do they compare? Elanco Animal Health Incorporated Common Stock trades at $22.69 (market cap $11.26B), while Kimberly Clark Corp trades at $97.7 (market cap $32.51B). The key difference: Kimberly Clark Corp is far larger — about 2.9× Elanco Animal Health Incorporated Common Stock's market cap, and Kimberly Clark Corp pays a 5.24% dividend while Elanco Animal Health Incorporated Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Elanco Animal Health Incorporated Common Stock for 0 Days and Kimberly Clark Corp for 93 Days on average.
| ELAN | KMB | |
|---|---|---|
Market Cap | $11.26B | $32.51B |
Volume | 4,570,386 | 6,139,913 |
Sector | Health | Consumer Staples |
52-Week High | $26.84 | $121.44 |
52-Week Low | $19.76 | $93.05 |
Typical Hold Time | 0 Days | 93 Days |
Enterprise Value | $14.65B | $38.07B |
Dividend Yield | — | 5.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Kimberly-Clark (KMB) trades at $96.48, down 0.3% on the day, showing bearish technical signals with recent price weakness. The company maintains strong profitability with 11.79% net margins and 129.43% ROE, though revenue declined to $16.45B in 2025. Recent Q2 2026 earnings missed expectations, while analyst consensus remains cautiously optimistic with a $117.25 price target. Key developments include executive transitions and ongoing Kenvue acquisition negotiations with EU regulators.
KMB presents a mixed investment case with attractive 5.16% dividend yield and 54-year dividend growth streak, but faces execution risks from the Kenvue acquisition and cash flow pressures. The stock trades below analyst targets with bearish technical momentum, requiring careful monitoring of merger integration and cash flow sustainability for dividend investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Elanco Animal Health Incorporated Common Stock
Elanco develops medicines, vaccines, and other health products for pets and livestock. Its products address prevention and treatment of animal diseases.
Read more on ELAN →About Kimberly Clark Corp
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →
